Short answer
HCA Healthcare (HCA) filed an 8-K current report with the SEC on April 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). HCA reported first-quarter results for the period ended March 31, 2026.
HCA Healthcare 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- HCA reported first-quarter results for the period ended March 31, 2026
- Earnings details and management commentary appear in Exhibit 99.1
- Results announcement dated April 24, 2026, providing the latest operating update to investors
Item 7.01 · Regulation FD Disclosure
- First-quarter 2026 results released for period ended March 31, 2026
- Detailed operating results and management commentary contained in Exhibit 99.1
- Regulation FD disclosure provides investors with HCA’s latest quarterly performance update
Item 8.01 · Other Events
- Quarterly cash dividend declared at $0.78 per common share
- Payment scheduled for June 30, 2026
- Record date set for June 16, 2026
- Dividend declaration signals continued shareholder-return commitment
Item EX-99.1 · Exhibit EX-99.1
- Q1 2026 revenue rose 4.3% to $19.109B, while net income increased 0.6% to $1.620B
- EPS increased 10.9% to $7.15, aided by diluted shares falling to 226.652M from 249.440M
- Adjusted EBITDA grew 1.9% to $3.802B, but margin compressed to 19.9% from 20.4%
- Same-facility equivalent admissions rose 1.3%, offsetting respiratory admissions down 42% and emergency visits down 32%
- 2026 guidance reaffirmed: revenue $76.5B-$80.0B, EPS $29.10-$31.50, Adjusted EBITDA $15.55B-$16.45B
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HCA Healthcare 8-K filings
Get the next HCA 8-K as it lands
Follow HCA for push alerts, or ask the research agent what this filing means.